Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

A gene deletion in mice causes weak protein, immune issues, hair loss, airway problems, and wasting disease.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.

Chitosan-based dressings reduce inflammation and speed up skin wound healing.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

CBD can either promote or inhibit hair growth depending on the concentration used.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Helminth protein helps wounds heal better by reducing scarring and promoting tissue growth.

Histone modification is key in treating chronic inflammatory skin diseases.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

The document explains various skin conditions and their treatments.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Psoriasis treatments range from topical creams to systemic medications with serious side effects, and while treatments can manage symptoms, there is no cure.

Skin issues can indicate immune system problems.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

ATP-dependent chromatin-remodeling complexes are crucial for gene regulation, cell differentiation, and organ development in mammals.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.